GSK Plc Valuation
| G1SK34 Stock | BRL 41.07 0.29 0.71% |
At this time, the firm appears to be overvalued. GSK plc retains a regular Real Value of R$35.82 per share. The prevalent price of the firm is R$41.07. Our model calculates the value of GSK plc from analyzing the firm fundamentals such as Return On Equity of 0.31, operating margin of 0.25 %, and Return On Asset of 0.0659 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that GSK Plc's price fluctuation is very steady at this time. Calculation of the real value of GSK plc is based on 3 months time horizon. Increasing GSK Plc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GSK Plc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GSK Stock. However, GSK Plc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 41.07 | Real 35.82 | Hype 41.07 | Naive 43.0 |
The real value of GSK Stock, also known as its intrinsic value, is the underlying worth of GSK plc Company, which is reflected in its stock price. It is based on GSK Plc's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GSK Plc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GSK plc helps investors to forecast how GSK stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GSK Plc more accurately as focusing exclusively on GSK Plc's fundamentals will not take into account other important factors: GSK Plc Total Value Analysis
GSK plc is currently projected to have takeover price of 484.56 B with market capitalization of 388.07 B, debt of 19.76 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the GSK Plc fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
484.56 B | 388.07 B | 19.76 B |
GSK Plc Investor Information
The book value of the company was currently reported as 5.25. The company has Price/Earnings To Growth (PEG) ratio of 0.45. GSK plc recorded earning per share (EPS) of 6.69. The entity last dividend was issued on the 23rd of February 2023. The firm had 4:5 split on the 20th of July 2022. Based on the measurements of operating efficiency obtained from GSK Plc's historical financial statements, GSK plc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.GSK Plc Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. GSK Plc has an asset utilization ratio of 43.13 percent. This suggests that the Company is making R$0.43 for each dollar of assets. An increasing asset utilization means that GSK plc is more efficient with each dollar of assets it utilizes for everyday operations.GSK Plc Profitability Analysis
The company reported the revenue of 34.11 B. Net Income was 4.38 B with profit before overhead, payroll, taxes, and interest of 19.92 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates GSK Plc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in GSK Plc and how it compares across the competition.
About GSK Plc Valuation
The stock valuation mechanism determines GSK Plc's current worth on a weekly basis. Our valuation model uses a comparative analysis of GSK Plc. We calculate exposure to GSK Plc's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GSK Plc's related companies.8 Steps to conduct GSK Plc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates GSK Plc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct GSK Plc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain GSK Plc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine GSK Plc's revenue streams: Identify GSK Plc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research GSK Plc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish GSK Plc's growth potential: Evaluate GSK Plc's management, business model, and growth potential.
- Determine GSK Plc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate GSK Plc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for GSK Stock analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |